Dr. Nicole Christine Cabbad, MBA, MD

Dr. Cabbad practices at Advanced Dermatology and Cosmetic Surgery in Orlando, Florida.

Dr. Cabbad's NPI, 1306133004, was assigned on July 1, 2011. Dr. Cabbad graduated from Yale School of Medicine in 2010. Dr. Cabbad holds Florida license ME131243.

Dr. Cabbad's primary practice is Advanced Dermatology and Cosmetic Surgery, at 14050 Town Loop Blvd, Orlando, FL 32837 in Orange County. The practice phone is (407) 333-4200.

Dr. Cabbad's primary practice is Advanced Dermatology and Cosmetic Surgery in Orlando, Florida. The medical group on file is Advanced Dermatology and Cosmetic Surgery. Dmand AI also links Dr. Cabbad to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cabbad practices. Vendor and product names are available with a free account.

Plastic surgery is Dr. Cabbad's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Cabbad is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Cabbad's licenses on file in 2 states: Florida and New York.

Dmand AI lists cancerous skin growth removal, head wound and minor head injury among the conditions Dr. Cabbad treats.

CMS data shows 1,072 Medicare services from Dr. Cabbad across 15 procedure codes in 2024, for 628 Medicare patients. Medicare paid $259,403 for them. Every service was in an office.

CMS counts 628 Medicare patients who saw Dr. Cabbad in 2024. The largest group is 75 to 84, with 269 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cabbad's median patient age at 76, with 42% women.

In 2024, Dr. Cabbad wrote 1,861 Medicare Part D claims for 1,009 patients. 100% of them were for generic drugs. CMS names the drug for 1,828 of them, across 6 drugs with 11 or more claims each, at $22,178 in total drug cost. In 2023, CMS named 1,264 claims across 7 drugs.

Dr. Cabbad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 45 procedures of melanoma (skin cancer) excision by Dr. Cabbad, more than 85% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Cabbad in 2025. Dr. Cabbad's most frequent co-authors are Kimberly A. Davis, MD, Victoria Marie Dukharan and Kyle Nuland, MD.

CMS Open Payments shows 21 general payments to Dr. Cabbad from 14 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 80% of the total. Abbvie Inc. paid the most, $246.

Dr. Cabbad graduated from Yale School of Medicine in 2010.

Dr. Cabbad is in network with 8 carriers, including Aetna, Cigna and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.